Growing evidence emphasizes the role of astrocytes and microglia in Parkinson’s disease (PD) and Alzheimer’s disease (AD). Yet, little is known about their impact on specific disease processes and if their involvement is beneficial or detrimental. The aim of this thesis was to further investigate the role of astrocytes and microglia in PD and AD. To this purpose, cultured human astrocytes and microglia were exposed to aggregates of alpha-synuclein (αSYN) or amyloid-beta (Aβ), proteins that are central to PD and AD brain pathology, respectively. In Paper I, the toxicity and cell-to-cell spreading of aggregated αSYN in human astrocytes were evaluated. We found that astrocytes can engulf large amounts of αSYN aggregates, which are stored insid...
International audienceRecent evidence suggests that disease progression in Parkinson's disease (PD) ...
In Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), aggregated α-synuclein deposit insi...
In Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), aggregated α-synuclein deposit insi...
Background Alzheimer’s disease (AD) and Parkinson’s disease (PD) are characterized by brain accumula...
BACKGROUND: Many lines of evidence suggest that accumulation of aggregated alpha-synuclein (αSYN) in...
Abstract Background Alzheimer’s disease (AD) and Park...
Background Many lines of evidence suggest that accumulation of aggregated alpha-synuclein (αSYN) in ...
Knowledge about the cellular mechanisms behind the initiation and propagation of Alzheimer’s disease...
Synucleinopathies are neurodegenerative disorders characterized by intracellular protein aggregates,...
Knowledge about the cellular mechanisms behind the initiation and propagation of Alzheimer’s disease...
Selective loss of neurons, abnormal protein deposition and neuroinflammation are the common patholog...
Recent evidence suggests that disease progression in Parkinson’s disease (PD) could occur by the spr...
Alzheimer's disease is a neurodegenerative disease that affects the central nervous system and is ch...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized pathologically by...
Recent evidence suggests that disease progression in Parkinson’s disease (PD) could occur by the spr...
International audienceRecent evidence suggests that disease progression in Parkinson's disease (PD) ...
In Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), aggregated α-synuclein deposit insi...
In Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), aggregated α-synuclein deposit insi...
Background Alzheimer’s disease (AD) and Parkinson’s disease (PD) are characterized by brain accumula...
BACKGROUND: Many lines of evidence suggest that accumulation of aggregated alpha-synuclein (αSYN) in...
Abstract Background Alzheimer’s disease (AD) and Park...
Background Many lines of evidence suggest that accumulation of aggregated alpha-synuclein (αSYN) in ...
Knowledge about the cellular mechanisms behind the initiation and propagation of Alzheimer’s disease...
Synucleinopathies are neurodegenerative disorders characterized by intracellular protein aggregates,...
Knowledge about the cellular mechanisms behind the initiation and propagation of Alzheimer’s disease...
Selective loss of neurons, abnormal protein deposition and neuroinflammation are the common patholog...
Recent evidence suggests that disease progression in Parkinson’s disease (PD) could occur by the spr...
Alzheimer's disease is a neurodegenerative disease that affects the central nervous system and is ch...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized pathologically by...
Recent evidence suggests that disease progression in Parkinson’s disease (PD) could occur by the spr...
International audienceRecent evidence suggests that disease progression in Parkinson's disease (PD) ...
In Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), aggregated α-synuclein deposit insi...
In Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), aggregated α-synuclein deposit insi...